Andexanet Alfa Reduces Hematoma Expansion in Intracerebral Hemorrhage Patients Receiving Factor Xa Inhibitors: NEJM Dr Riya Dave22 May 2024 7:45 AM ISTResearchers have investigated the efficacy and safety of andexanet alfa, a reversal agent for factor Xa inhibitors, in patients with acute...
Magnesium exerts hemostatic effects in intracerebral haemorrhage by reduced hematoma expansion: FAST-MAG analysis Medha Baranwal5 Jan 2024 6:00 PM ISTUSA: The hemostatic effects of magnesium (Mg) in intracerebral haemorrhage are supported by reduced hematoma expansion in participants of the FAST-MAG...
Desmopressin may not reduce hematoma expansion in ICH associated with antiplatelet therapy Dr. Shravani Dali22 March 2022 9:00 AM ISTDesmopressin administration in patients with spontaneous antiplatelet-associated ICH is not associated with a reduction in poor outcomes, according...
Prior antiplatelet therapy tied to adverse outcomes in intracerebral hemorrhage: Study Medha Baranwal12 March 2021 8:49 PM ISTUK: Prior antiplatelet therapy in intracerebral hemorrhage (ICH) patients increases risk of hematoma expansion and leads to less favorable outcomes...
